Sort
48,018 grants matching “immunotherapy”
Neutrophils and Monocytes in Pediatric Ischemic Stroke
$430,947Chia-Yi Kuan · University Of Virginia · R01 · FY2022 · NS
Neutrophils and Monocytes in Pediatric Ischemic Stroke
$430,947Chia-Yi Kuan · University Of Virginia · R01 · FY2023 · NS
Neutrophils and Monocytes in Pediatric Ischemic Stroke
$430,947Chia-Yi Kuan · University Of Virginia · R01 · FY2025 · NS
HTS for the discovery of activators of NK cell cytotoxicity
$430,887David Wald · Case Western Reserve University · R01 · FY2022 · CA
Regulated gene circuits for Alzheimer's disease therapy
$430,884Jonathan Matthew Brunger · Vanderbilt University · R21 · FY2024 · AG
Synthetic Studies Related to Cancer Research/Treatment
$430,815Paul Wender · Stanford University · R01 · FY2023 · CA
Roles of Coactivator-Associated Arginine Methyltransferase 1 in B cell activation and lymphomagenesis
$430,783Margarida Santos · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Novel cell therapy approaches for molecularly defined subsets of therapy-resistant melanoma
$430,781Christopher Austin Klebanoff · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Microfluidic sorting of lung cancer cells from leukapheresis product as an alternative to metastatic tumor biopsy
$430,769Mehmet Toner · Massachusetts General Hospital · R01 · FY2024 · CA
Project 3: A novel telomere-targeted agent for neoadjuvant therapy of early-stage HCC
$430,751Adam Yopp · Ut Southwestern Medical Center · P50 · FY2025 · CA
Mutational signature analysis: methods and applications to the clinic
$430,741Peter Park · Harvard Medical School · R01 · FY2024 · CA
Project 2: A Novel Cellular Tumor Vaccine Strategy for Glioblastoma
$430,716Michael D Gunn · Duke University · P01 · FY2019 · CA
Synthetic Studies Related to Cancer Research/Treatment
$430,697Paul Wender · Stanford University · R01 · FY2025 · CA
Targeting defective necroptosis in colorectal cancer
$430,693Lin Zhang · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP
$430,690Vanderbilt University · U10 · FY2003 · CA
T memory stem cells in cancer
$430,580Yiping Yang · Duke University · R01 · FY2019 · CA
Targeting the DNA damage response in combination with radiation to induce innate immunity and improve immunotherapy efficacy in pancreatic cancer
$430,481Meredith A Morgan · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Synthetic Studies Related to Cancer Research/Treatment
$430,458Paul Wender · Stanford University · R01 · FY2018 · CA
Metabolic Barriers to T Cell Activation in Clear Cell Renal Cell Carcinoma
$430,452Jeffrey C Rathmell · Vanderbilt University Medical Center · R01 · FY2022 · CA
What fuels CAR T-cell serial killing
$430,406Roderick O'Connor · University Of Pennsylvania · R01 · FY2023 · CA
Targeting Transcriptional Regulators for Immunotherapy of Acute Myeloid Leukemia
$430,377Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2021 · CA
Targeting Transcriptional Regulators for Immunotherapy of Acute Myeloid Leukemia
$430,377Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2018 · CA
Project 3: Determination of the minimal MHC-E-restricted SIV epitope targeting required for RhCMV/SIV vaccine-mediated SIV replication arrest efficacy
$430,365Louis J. Picker · Oregon Health & Science University · P01 · FY2022 · AI
DEVELOPMENTAL FUNDS
$430,340William L. Carroll · New York University School Of Medicine · P30 · FY2015 · CA
Project #3:Active Vaccination and Immunotherapy Against Coccidioidomycosis
$430,315Chiung-Yu Hung · University Of Texas San Antonio · U19 · FY2024 · AI